| – | Discuss previous knee surgery, as well as joint disabilities |
| – | Discuss frequency of bleeding episodes, response to treatment of bleeds |
| – | Discuss available therapies and how they can best be used |
| – | Consider inhibitor eradication strategies |
| – | Disease overview |
| – | Patient education regarding situations in which factor administration may be necessary, and appropriate dosing, ability to self-infuse |
| – | Brief discussion of potential future health care interventions and how those can be coordinated |
| – | Performed an assessment on musculoskeletal and functional status, with focus on knees and elbows |
| – | Discussed bleed prophylaxis based on the avoidance of specific activities |
| – | Recommend PT for general strengthening of muscles and protection of joints |
| – | Discussed patient concerns related to increasing disability – personal and family impact |
| – | Discuss concerns about insurance coverage for increasingly costly therapies |
Cindy Leissinger, MDProfessor of Medicine, Pediatrics & Pathology Chief, Section of Hematology & Medical Oncology Tulane University School of Medicine |
|